Prof. Dr. med. Axel Merseburger is Professor of Urology and Chairman of the Department of Urology at University Hospital Schleswig‑Holstein, Campus Lübeck, Germany. After graduating from Hannover Medical School in 2002, he carried out a residency in surgery and urology at the Eberhard Karls University, in Tübingen, followed by a research fellowship at the Miller School of Medicine, Miami, USA (2006). He became Associate Professor in 2009 and full Professor in 2012 at Hannover Medical School.Professor Merseburger is a member of various uro-oncology organisations and serves as an advisor for the European Association of Urology (EAU) Guideline Group for Renal Cancer and was the Chairman of the EAU Guideline Group for Lasers and Technologies. He acts as reviewer and editorial board member for several urology and oncology indexed journals and is associate editor of the World Journal of Urology and editor in Chief of European Oncology & Haematology Journal.Professor Merseburger’s research activity encompasses both molecular and clinical aspects of uro-oncology, with specific interest in biomarkers and prognostic factors for prostate cancer, renal cell carcinoma and transitional cell carcinoma. He has authored and co-authored more than 200 peer-reviewed articles and he is the principal investigator in multiple phase II and III clinical trials.